RT Journal Article
SR Electronic
T1 MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003917
DO 10.1136/jitc-2021-003917
VO 10
IS 3
A1 Prasad, Manu
A1 Zorea, Jonathan
A1 Jagadeeshan, Sankar
A1 Shnerb, Avital B
A1 Mathukkada, Sooraj
A1 Bouaoud, Jebrane
A1 Michon, Lucas
A1 Novoplansky, Ofra
A1 Badarni, Mai
A1 Cohen, Limor
A1 Yegodayev, Ksenia M
A1 Tzadok, Sapir
A1 Rotblat, Barak
A1 Brezina, Libor
A1 Mock, Andreas
A1 Karabajakian, Andy
A1 Fayette, Jérôme
A1 Cohen, Idan
A1 Cooks, Tomer
A1 Allon, Irit
A1 Dimitstein, Orr
A1 Joshua, Benzion
A1 Kong, Dexin
A1 Voronov, Elena
A1 Scaltriti, Maurizio
A1 Carmi, Yaron
A1 Conde-Lopez, Cristina
A1 Hess, Jochen
A1 Kurth, Ina
A1 Morris, Luc G T
A1 Saintigny, Pierre
A1 Elkabets, Moshe
YR 2022
UL http://jitc.bmj.com/content/10/3/e003917.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.